In the BioHarmony Drug Report Database

"Preview" Icon

Abacavir

Ziagen (abacavir) is a small molecule pharmaceutical. Abacavir was first approved as Ziagen on 1998-12-17. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. The pharmaceutical is active against Gag-Pol and Gag-Pol polyprotein.

 

Trade Name

 

Ziagen
 

Common Name

 

abacavir
 

ChEMBL ID

 

CHEMBL1380
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals: carbocyclic nucleosides

Image (chem structure or protein)

Abacavir structure rendering